Zatz R, Meyer T W, Rennke H G, Brenner B M
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5963-7. doi: 10.1073/pnas.82.17.5963.
Six groups of Munich-Wistar rats underwent micropuncture study 2-10 weeks and morphologic studies 11-13 months after induction of streptozotocin diabetes or after sham treatment. Diabetic rats received diets containing 6% (group D6), 12% (D12), or 50% protein (D50) and were maintained under similar conditions of moderate hyperglycemia by daily injections of ultralente insulin. Age- and weight-matched normal control rats were also given 6% (Group N6), 12% (N12), or 50% protein (N50). Kidney weight, whole-kidney and single-nephron glomerular filtration rate, glomerular plasma flow, and mean glomerular transcapillary hydraulic pressure difference were higher in D50 rats than in all other groups and predisposed this group to marked and progressive albuminuria. Likewise, histological examination of the kidneys disclosed areas of sclerosis in 19.6% of glomeruli in D50 rats; the frequency of such lesions was less than 2.5% in all other groups. These findings indicate that the metabolic disorder seen in stable, moderately hyperglycemic diabetic rats does not lead to glomerulopathy as long as elevations in glomerular pressures and flows are prevented.
六组慕尼黑-威斯塔大鼠在链脲佐菌素诱导糖尿病后或假处理后2至10周接受微穿刺研究,并在11至13个月后进行形态学研究。糖尿病大鼠接受含6%(D6组)、12%(D12组)或50%蛋白质(D50组)的饮食,并通过每日注射长效胰岛素维持在中度高血糖的相似条件下。年龄和体重匹配的正常对照大鼠也给予6%(N6组)、12%(N12组)或50%蛋白质(N50组)。D50组大鼠的肾脏重量、全肾和单肾单位肾小球滤过率、肾小球血浆流量以及平均肾小球跨毛细血管液压压差均高于所有其他组,且使该组大鼠易发生明显且进行性蛋白尿。同样,对肾脏的组织学检查发现,D50组大鼠19.6%的肾小球出现硬化区域;所有其他组中此类病变的发生率均低于2.5%。这些发现表明,只要防止肾小球压力和流量升高,稳定的中度高血糖糖尿病大鼠中出现的代谢紊乱不会导致肾小球病变。